Epilepsy and COVID-19

Professor John Leach, University of Glasgow, reviews the impact of COVID-19 on the management of epilepsy.

Professor John Paul Leach has received speaker's Honoraria and Advisory Board Honoraria from UCB, EISAI, Pfizer, Desitin, GW Pharma, Glaxo Smithkline, Janssen-Cilag. UCB provided an unrestricted educational grant for a research fellow under John Paul Leach over 2 Years from 2015.